Life Sciences

TSRL Receives Second-Year NIH Notice of Award to Advance Microneedle Patch for Overactive Bladder Therapy

Nearly $1.1 million in continued funding supports development of TSRL’s Trospium Chloride microneedle delivery platform TSRL, Inc., a preclinical contract research organization (CRO) specializing in...

TrialAssure® ANONYMIZE® Selected by the European Medicines Agency as Official Anonymisation Tool

TrialAssure®, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that its ANONYMIZE® platform has been selected by the...